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Abstract We studied the effect of protein kinase C (PKC) 
inhibition and activation on voltage-dependent Ca2+ channels in 
rat insulinoma RINm5F cells. PKC down-regulation by chronic 
(24 h) treatment with the PKC activator phorbol 12-myristate 
13-acetate (PMA) reduced by about 60% the Ba 2+ currents 
through L- and non-L, non-N-type high-voltage-activated Ca2+ 
channels, indicating that PKC tonically up-regulates the two 
main Ca 2+ channel subtypes of RINm5F cells under basal 
conditions. Consistently, PKC activation by acute PMA 
application caused only a modest increase (average 23%) of 
2+ Ba currents in a minority of cells (24%). L- and non-L, non-N- 
type channels were differentially up-regulated by either basal or 
stimulated PKC activation. Acute up-regulation was predomi- 
nant on L-type channels and caused an I/V shift of the Ba 2+ 
currents in the hyperpolarizing direction. Non-L, non-N-type 
channels were less affected by acute PMA application, possibly 
reflecting a more effective tonic PKC up-regulatory action. 
Unexpectedly, the increase of Ba z+ currents during acute PMA 
application was followed by a progressive current decrease, which 
was also observed in isolation in another 24% of the cells and 
could be ascribed to PKC-induced ATP depletion, rather than to 
a direct effect of PKC on Ca 2+ channels. We also provide 
evidence that PKC-mediated phosphorylation is not involved in 
the G-protein-mediated noradrenergic modulation of Ca 2+ 
channels in RINm5F cells. 
channels are also implicated in insulin release from human 13 
cells [10] and catecholamines secretion from chromaffin cells 
[11] and that they can be up-regulated by PKC activation in 
neurons [12,13], PKC-dependent phosphorylation of these 
channels in RINm5F cells may be relevant o the overall 
secretory activity of these cells. 
Here we show that both L- and non-L, non-N-type Ca 2+ 
channels are effectively up-regulated by PKC-dependent phos- 
phorylation under basal conditions. In agreement with this, 
stimulation of PKC by acute application of phorbol ester 
causes only minor up-regulation of both channel subtypes, 
with a net prevalence of the L-type. Since PKC-induced phos- 
phorylation has been proved to disrupt neurotransmitter in- 
hibition on Ca 2+ channels in different neurons and secretory 
cells [13-16], we also tested its direct involvement in the G- 
protein-mediated noradrenergic inhibition of Ca 2+ channels 
[17]. The present findings exclude any relation between or- 
adrenergic and PKC-mediated Ca 2+ channels modulation, but 
underline the essential role of PKC-dependent phosphoryl- 
ation in tonically maintaining voltage-dependent Ca 2+ chan- 
nels in a functional state. 
2. Materials and methods 
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1. Introduction 
Insulin release from pancreatic 13 cells is a complex process 
regulated by changes of ion channel permeability, intracellular 
levels of cyclic nucleotides, phosphoinositide turnover, kinases 
and phosphatases activity [1]. Protein kinase C (PKC) is 
thought o play a critical role in the modulation of stimu- 
lus-secretion coupling, but the mechanisms of this action are 
still unclear. In rat insulinoma RINm5F cells, PKC activation 
promotes insulin release [2], possibly through a phosphoryl- 
ation-mediated closure of ATP-regulated K-- channels [3,4], 
which in turn induces membrane depolarization and Ca 2+ 
entry [4,5]. Parallel to this mechanism, a PKC-mediated reg- 
ulation of voltage-dependent L-type channels has also been 
proposed [6,7], but it remains to be elucidated whether other 
Ca 2+ channel subtypes are also involved in the phenomenon. 
This is of importance since RINm5F cells do not express only 
L-type Ca z+ channels, but also N-type [8] and non-L, non-N- 
type (Q-like) channels [9]. Given that non-L, non-N-type 
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2.1. Cell culture and solutions 
Rat insulinoma RINm5F cells were cultured as previously described 
[8]. Experiments were carried out 3-7 days after plating. The external 
perfusion solution contained (mM): 125 NaC1, 10 BaCI~, 1 MgClz, 10 
4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid (HEPES), and 0.3 
gM tetrodotoxin (pH 7.3 with CsOH). The internal pipette solution 
contained (mM): 110 CsCI, 30 tetraethylammonium chloride 
(TEAC1), 2 MgC12, 10 ethylenebis (oxonitriol) tetraacetate (EGTA), 
8 glucose, 10 HEPES and 4 Mg-ATP (pH 7.3 with CsOH). In some 
experiments 15mM phosphocreatine (Sigma Chemical Co., St. Louis, 
MO, USA) and 0.3 mM guanosine-5'-triphosphate (GTP, Sigma 
Chemical Co.) were added to the internal solution. The bath Tyrode 
solution contained (mM): 150 NaC1, 4 KC1, 2 MgC12, 2 CaC12, 10 
glucose and 10 HEPES. Nifedipine was dissolved in ethanol 95%, 
diluted daily to 5 gM in the bath solution and applied under light 
protection. Chronic treatment with 3.2 gM 0~-conotoxin (c0-CTx) 
GVIA (Bachem AG, Bubendorf, CH) was carried out by 20 min 
dish incubation in Tyrode's olution prior to recording. 4ct- and 4[~- 
phorbol 12-myristate 13-acetate (PMA) were purchased from Sigma 
Chemical Co. and from ICN (Aurora, OH, USA), dissolved at 1.62 
mM in DMSO and stored at -20°C. Final concentrations were 0.03- 
0.3 gM in the external solution for acute application and 1 gM in 
RPMI medium for 24 h PKC down-regulation [18]. Protein kinase C 
pseudosubstrate (PKCI(19-36)) was purchased from Bachem AG, dis- 
solved in 0.5% acetic acid (20 mM) and stocked at -20°C. Final 
dilution to 5-20 gM in the internal solution was carried out daily. 
Noradrenaline bitartrate (Sigma Chemical Co.) was dissolved aily to 
20 gM in the external solution. A multi-barrelled glass pipette was 
used for bath solution exchanges [8]. 
2.2. Electrophysiological measurements and analysis 
Whole-cell currents were measured by a List EPC-7 patch-clamp 
amplifier and borosilicate glass electrodes of 3~5 Mf~ resistance [8]. 
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Stimulation and acquisition were performed using a 12-bit A/D Tec- 
mar Labmaster board operated by pClamp software (Axon Instru- 
ments, Forster City, CA). Current races were sampled at digitizing 
rates of 10-40 kHz, filtered at 5-10 kHz and analyzed with AutesP 
program (Garching Innovation, Munich, Germany). Step depolariza- 
tions of variable amplitude (-40 to +90 mV) and duration (80 to 100 
ms) were applied at 1~30 s intervals from a holding potential (Vh) of 
--90 mV. Capacitive transients and leakage currents were compen- 
sated electronically and by subtracting either Cd2+-insensitive currents 
persisting after bath addition of 200 ktM CdC12 or scaled P/4 hyper- 
polarizing pulses. Current amplitude was measured at the peak and 
divided by the cell capacitance to account for the cell size. Capaci- 
tance measurements were obtained from the Cstow setting after com- 
pensation. The time-dependent decay of Ba ~+ currents in control con- 
ditions ('run-down') was measured in 4 cells stimulated for 15 min 
with 100-ms pulses to +10 mV repeated every 30 s. Averaged normal- 
ized current decays were fitted with a regression li e, whose slope was 
taken as the standard run-down of Ba 2+ currents (see Figs. 2A and 3). 
The delayed epression ofCa 2+ currents induced by PMA application 
was estimated in a similar way and compared to the control run- 
down. Results were considered significant only when the slope of 
the PMA-induced ecay differed by more than 3 times the standard 
deviation from the control run-down (see Fig. 3A). Data are ex- 
pressed as means + S.E.M. for n cells. All experiments were performed 
at room temperature (20-22°C). Statistical significance (P) was calcu- 
lated using Student's t-test for unpaired ata. 
3. Results 
In order to evaluate whether Ca 2+ channels in RINm5F 
cells are tonically regulated by PKC-dependent phosphoryl- 
ation we first compared control Ba 2+ currents with currents of 
cells in which PKC activity was fully inactivated by 24 h 
incubation with 1 I.tM PMA [18]. As illustrated in Fig. 1A, 
Ba 2+ currents in PKC down-regulated cells were smaller than 
in control cells, and showed almost no differences in both the 
activation-inactivation kinetics and in the voltage dependence 
of the current-voltage (I-V) relationship (Fig. 1B). In 27 
down-regulated cells the mean peak current at 0/+10 mV 
was 18.8 + 2.2 pA/pF, corresponding to 40.4% of the mean 
peak current measured in control conditions (46.5+4.1 pA/ 
pF, n = 34) (Fig. 1B inset). To exclude any non-specific effect 
of PMA on Ca r+ channels, Ba 2+ currents were also recorded 
from cells incubated for 24 h with the PMA analogue 4a- 
PMA (1 gM), which is inactive with regard to PKC activa- 
tion. The mean peak current after 4a-PMA pre-treatment 
differed by less than 1% from that recorded in control condi- 
tions (n = 12, not shown). Thus, Ca r+ channels appear already 
effectively up-regulated by PKC-dependent phosphorylation 
under basal conditions and the fraction of current lost in 
PKC-depleted cells may be taken as an indication of the de- 
gree of endogenous PKC-dependent up-regulation (,~ 60%). 
Next, we tested which channel subtype was involved in this 
process by using saturating doses of to-CTx-GVIA (3.2 gM) 
and nifedipine (5 gM) to selectively block N- and L-type 
channels in PKC down-regulated cells. As shown in Fig. 1C, 
non-N-type current (recorded in the presence of o~-CTx- 
GVIA), non-L, non-N-type current (recorded in the presence 
of (o-CTx-GVIA and nifedipine) and L-type current (esti- 
mated from the current block by nifedipine) were depressed 
to about the same percentage (46.19-53.88%, n = 20). Due to 
the modest contribution of the N-type channel to the total 
current in RINm5F cells (10-15%) [8,9], we were unable to 
evaluate the endogenous action of PKC on this Ca r+ channel 
subtype. 
Consistently with these data, we found that PKC activation 
1). Platano et al./FEBS Letters 391 (1996) 189-194 
by acute PMA application (30-300 nM) caused an average 
23% increase of Ba ~+ current amplitude in 24% of the tested 
cells (n = 50). The effect was PKC-mediated since it was never 
observed in the presence of the PKC-inhibitor PKCI(19-36) in 
the internal perfusate (25-50 ~tM, n = 9), in PKC down-regu- 
lated cells (n= 12) or using the inactive analogue 4a-PMA 
(n = 5). The time course of the Ba 2+ current increase was si- 
milar in all the cells studied (Fig. 2A). The maximum was 
reached within 45 s, lasted 1-2 rain and then declined with 
a slope steeper than the average Ba 2+ current run-down 
(straight line in Fig. 2A) (see below). The channel activa- 
tion-inactivation kinetics were never altered by PMA (Fig. 
2B). In four cells, the current up-regulation was most evident 
between -30 and -10  mV, reaching maximal amplitude at 
around -15 mV (Fig. 2C). Thus, the I-V relationship asso- 
ciated with the up-regulated current was clearly shifted toward 
more negative potentials (dashed line in Fig. 2C), i.e. in the 
voltage region where L-type channels activate in RINm5F 
cells [8]. In 8 out of 12 cells the current increase was almost 
completely abolished by nifedipine (5 IxM), confirming that 
the I-V shift was mainly due to L-type Ca 2+ current up-reg- 
ulation, rather than to a decrease of the voltage threshold for 
Ca 2+ channel activation. In the two examples of Fig. 2D, the 
action of nifedipine was compared before (NIFE) and after 
acute application of PMA (NIFE + PMA). In one case (Fig. 
2D1), the current amplitude recorded in the presence of PMA 
plus nifedipine was the same as in nifedipine alone, suggesting 
that the dihydropycidine (DHP) abolished both the PMA-in- 
duced current and the L-type current expressed by the cell. In 
the second case (Fig. 2D2), the L-type current prior to phor- 
bol ester application was undetectable (compare traces C and 
NIFE), but nifedipine was nevertheless able to block the 
PMA-induced current. The up-regulating action of PKC was 
not limited to L-type channels. An example of PKC-induced 
current increase involving non-L, non-N-type channels is 
shown in Fig. 2E. The non-L, non-N-type current recorded 
from an o~-CTx-GVIA-treated cell exposed to nifedipine was 
increased following PMA application. Similar effects were ob- 
served in two other cells. 
As mentioned above, PMA had also a depressing action 
that varied from cell to cell and occurred either overlapped 
to the Ba 2+ current increase (Fig. 2A) or in isolation (Fig. 
3A). In 12 out of 50 RINm5F cells the current decrease was 
significantly faster than the average Ba 2+ current run-down 
(straight line in Fig. 3A, see Section 2) and caused no changes 
to the activation-inactivation kinetics (inset). As for the cur- 
rent up-regulation, the Ba 2+ current decrease was very likely 
related to PKC activation, since it was not observed in 6 out 
of 7 down-regulated cells and in all the 4 control cells exposed 
to 4a-PMA. However, the current decrease induced by PMA 
could be largely prevented by adding a potent phosphate do- 
nor to the standard internal solution, such as 15 mM phos- 
phocreatine (n = 8) (Fig. 3B). This suggests that Ba 2+ current 
decrease induced by PMA was not due to a direct down-reg- 
ulating action of PKC on Ca r+ channels but, very likely, to a 
shortening of intracellular ATP that may derive from an in- 
creased overall PKC-phosphorylating activity. 
The last series of experiments was aimed at verifying 
whether PKC-dependent phosphorylation is involved in the 
G protein-mediated noradrenergic modulation of HVA Ca 2+ 
channels. Noradrenaline (NA) inhibits HVA Ca 2+ channels in 
RINm5F cells in a voltage-dependent a d -independent man- 
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Fig. 1. Effects of PKC down-regulation HVA Ba 2+ currents in RINm5F cells. A: HVA Ba 2+ currents recorded at potentials between -40 
and +20 mV, with 20 mV step increments, from a control cell (A1) and a PKC down-regulated cell (A2) of equal capacitance (5 pF); Vh --90. 
B: Normalized peak current-voltage relationship for 10 control (empty circles) and 7 down-regulated cells (filled circles). Bars represent S.E.M. 
Inset: Averaged normalized peak Ba z+ current values for 34 control and 27 down-regulated cells. C: Averaged normalized peak Ba 2+ current 
values for non-N, non-N, non-L- and L current components in 24 control and 20 down-regulated cells. All components appear equally de- 
pressed (48, 46.19 and 53.88% of control, respectively). 
ner, distinguishable on the basis of the response to strong 
depolarizing pre-pulses [8,17]. In order to ascertain whether 
NA-induced inhibition was due to an antagonistic action on 
basal PKC-induced Ca 2+ channel up-regulation, we studied 
the effects of NA with a two-pulse protocol (a test pulse to 
0 mV alone or preceded by a pre-pulse to +90 mV) in PKC- 
down-regulated (n= 7) and in control cells (n = 7). As shown 
in Fig. 4A, both voltage-dependent and -independent inhibi- 
tion were preserved in PKC-depleted cells. The strong current 
depression induced by NA (vertical arrow on trace c, Fig. 4A, 
right) was partially recovered by the pre-pulse (cf. horizontal 
arrow on trace d) indicating the persistence of both a voltage- 
dependent inhibition (trace d minus c) and a voltage-indepen- 
dent inhibition non-recovered by voltage (trace b minus d). 
Analogous results were obtained in two cells internally per- 
fused with 50 ~tM PKCI(19-36) (not shown). Finally, we com- 
pared in the same cell the effects of NA applied before (Fig. 
4B, top) or during acute application of PMA (Fig. 4B, bot- 
tom). The inhibitory action of NA was not significantly af- 
fected by PMA in any of the cells tested (n = 6), suggesting 
that the PKC action and the G-protein-mediated noradrener- 
gic Ca 2+ channel inhibition are independent processes [17]. 
4. Discussion 
Ca 2+ channels in R INm5F cells are up-regulated by PKC 
activation in an effective way. Most interestingly, PKC action 
is not confined to the L-type channel, as usually believed [6,7], 
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Fig. 2. Enhancement of HVA Ba 2+ currents by PMA in RINm5F cells. A: Time-course of HVA Ba 2+ current amplitude during 300 nM PMA 
perfusion in 5 selected cells. Each dot represents he peak current at -10 or 0 inV. Recordings are synchronized at the beginning of PMA per- 
fusion (bar); their amplitude is normalized at the control value of the trace preceding PMA application. R.D. marks the regression line of 4 
control cells in which the run-down was studied (see Section 2). Inset: Maximal PMA-induced Ba 2+ current increase in 12 cells compared with 
the corresponding run-down in 4 control cells. B: Current races recorded at 0 mV from a cell bathed in 10 mM Ba 2+, in control conditions 
(upper trace) and during PMA application (lower trace). Vh --90 mV. C: Normalized peak current-voltage relationship from 4 cells in control 
conditions (empty circles) and during application of 300 nM PMA (filled circles). Note the more negative peak of the enhanced current (differ- 
ence between the two curves, dotted line). D: Current races recorded at -10 mV (D1) and in a second cell at +10 mV (D2) in control condi- 
tions (C), in the presence of 5 IxM nifedipine (NIFE), in the presence of 300 nM PMA (PMA) and of both PMA and nifedipine (PMA+NIFE). 
E: Same as in D, but in an 0~-Ctx-GVIA-treated cell. Vtest +10 mV; Vh -90 mV. 
but also involves the non-L, non-N-type (Q-like) channel 
which is responsible for a large proportion of Ba 2-- currents 
in these cells [9]. This up-regulation is tonically active, as 
revealed by the strong current reduction in PKC-down-regu- 
lated cells, and targets both L- and non-L, non-N-type Ca 2+ 
channels. Despite this common feature, however, the two 
channels are differently up-regulated by stimulated PKC acti- 
vation. Acute cell exposure to PMA causes Ba 2+ current in- 
creases predominantly in a voltage range in which L-type 
channels are preferentially activated, and this effect is greatly 
reduced or even abolished by DHP antagonists. In some cells, 
PKC stimulation even recruits L-type currents that were un- 
detectable under basal conditions (Fig. 2D). This is in line 
with observations in hippocampal neurons, where L-type 
channel activity in cell-attached patches is strongly enhanced 
by phorbol esters [19]. On the other hand, PKC stimulation 
causes only a minor increase of the o)-CTx-GV1A- and DHP- 
resistant current in a small percentage of cells (Fig. 2E), sug- 
gesting that the non-L, non-N-type channel is already maxi- 
mally up-regulated by PKC in a tonic way. A parallel up- 
regulation of both L- and non-L-type (N and P/Q) channels 
has been shown in frog sympathetic neurons [20] and rat 
hippocampal pyramidal neurons [12]. 
Taken all together our findings are in good agreement with 
previous reports on the action of PKC on rodent 13 cells and 
13-cell lines. For instance, in mouse 13-cells the down-regulation 
of PKC activity causes a 50% reduction of Ca 2+ current am- 
plitude [21], suggesting that tonic up-regulation of Ca 2+ chan- 
nels may be a common property of insulin-secreting cells. In 
R INm5F cells, the PKC activator didecanoylglycerol (DiC10, 
12.5 ~tM) causes an increased open channel probability in cell- 
attached patches [7], while PMA (10 nM) enhances by 80% 
the whole-cell Ca z+ currents during acute application [6]. In 
these experiments, however, PMA was found to have no effect 
when applied for 48 h to down-regulate PKC. This might 
reflect a much lower level of endogenous PKC activity, due 
to different recording conditions (5 h rather than 3-7 days 
after plating, as in our case). An increased Ca 2+ channel ac- 
tivity due to PKC-enhanced channel phosphorylation is also 
in line with a recent report, in which the phosphatase inhibitor 
okadaic acid was shown to increase the Ca 2+ current of 
RINm5F cell at rather negative voltages [22]. This reinforces 
the concept hat L-type channels may be effectively up-regu- 
lated beyond the basal level, either by stimulating PKC-de- 
pendent phosphorylation or by inhibiting phosphatase activ- 
ity. 
A complication in our study was the existence of two con- 
trasting effects on Ca 2+ channels evoked by PKC activation: 
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a fast up-regulation and a delayed Ca 2+ current depression 
(Fig. 2A). We do not have a clear explanation for the origin 
of the latter effect, which could also be observed in isolation 
and was too fast to be confused with the slow and unspecific 
run-down of Ca 2+ channels occurring during cell dialysis. 
However, since the delayed Ba 2+ current depression was large- 
ly prevented by adding high doses of creatine phosphate to 
the intracellular medium, the phenomenon could be ascribed 
to the decreased level of ATP rather than to the direct effect 
of PKC on Ca 2+ channels. ATP depletion may be just the 
consequence of the increased metabolic needs resulting from 
the enhanced PKC activity toward the many available phos- 
phorylation sites inside the cell. This point, however, deserves 
further investigation. 
The final question we addressed was whether there was a 
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Fig. 3. Depression of HVA Ba 2+ currents by PMA. Time-course of 
HVA Ba 2+ current amplitude during application of 300 nM PMA, 
in the absence of phosphocreatine (n = 9, filled symbols in panel A) 
and in the presence of 15 mM phosphocreatine in the internal solu- 
tion (n=7, empty symbols in panel B). Different symbols corre- 
spond to different cells. Synchronization and normalization of the 
time courses as in Fig. 2A. The straight hick line is the averaged 
regression line obtained from 4 control cells, taken as the standard 
current run-down. The slope of current decay in PMA-treated cells 
is considered significantly different from that of run-down only 
when failing below the shaded area, representing 3 times the S.D. of 
the control run-down (1.87_+0.72% min -~ for panel A and 
2.25+0.4% min -1 for panel B). Insets: HVA Ba 2+ currents re- 
corded in control conditions (a) and after exposure to 300 nM 
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Fig. 4. Interactions between NA and PKC modulation of HVA Ca 
channels. A: Effects of 10 gM NA in a down-regulated cell. A test 
pulse to 0 mV was delivered alone (a, c) or preceded by a strong 
depolarization to +90 mV (b, d). Vertical arrows indicate the cur- 
rent peak in control conditions and the corresponding time in the 
trace with NA. In control conditions (left) the two traces virtually 
overlap, while the inhibition induced by NA (vertical arrow on the 
right) is partly recovered by the pre-pulse (horizontal arrow). 
Dotted lines help visualization of the current levels marked by hori- 
zontal arrows. B: Same as in A, in a control cell before (top panels) 
and during acute 300 nM PMA application (bottom panels). Hori- 
zontal arrows measure the pre-pulse-induced current facilitation 2 
ms after the onset of the test pulse. NA induces about the same 
V-dependent and V-independent Ba 2+ current depression before and 
during PMA perfusion, as evidenced by the dotted lines. Vh -90 
mV; Vtest 0 mV. 
ct2-adrenergic Ca 2+ channel inhibition [8,17], with PKC acti- 
vation possibly interfering with the G-protein-mediated, mem- 
brane-delimited mechanism. Support to this hypothesis comes 
from studies in central and peripheral neurons [12,13,15,23], 
where PKC activation is shown to increase Ca 2+ currents by 
removing the Ca 2+ channels inhibition induced by activated G 
proteins either tonically or through neurotransmitter recep- 
tors. We found, however, that this is not the case. Neither 
disruption of the tonic PKC phosphorylation i  down-regu- 
lated cells, nor acute PKC stimulation affected noradrenaline 
inhibition in R INm5F cells, in either its voltage-dependent or 
voltage-independent components. The same occurs in frog 
sympathetic neurons in which N- and L-type channels appear 
up-regulated by PKC activators, but the action is uncoupled 
from the Ca 2+ channel inhibition induced by 100 ktM intra- 
cellular GTP-7-S [20]. These findings suggest that PKC-in- 
duced phosphorylation and noradrenergic nhibition of Ca 2+ 
channels are independent processes in R INm5F cells, support- 
194 
ing the view that PKC phosphorylation may follow different 
pathways and target different sites depending on the Ca 2+ 
channels, G proteins and membrane receptors expressed by 
the cells (cf. [15,23]). 
In conclusion, we believe that the PKC-dependent Ca z+ 
channel activation described here provide complementary 
data to previously proposed schemes in which PKC activity 
has been implicated in the regulation of Ca 2+ influxes in re- 
sponse to insulin secretagogues. Like secretagogues, activation 
of PKC causes the closure of ATP-regulated K + channels [4] 
with consequent cell depolarization and Ca 2+ entry through 
voltage-dependent Ca 2+ channels. Alternatively, our findings 
suggest hat PKC-dependent phosphorylation of Ca 2+ chan- 
nels may support insulin release by directly up-regulating L-
and non-L-type channels, possibly without interfering with 
other Ca 2+ channel inhibitory mechanisms. The high level 
of PKC-mediated Ca 2+ channels up-regulation under basal 
conditions uggests that the maintenance of L-type and Q- 
like channels in a proper functional state might represent 
both a permissive factor in the regulation of insulin release 
and the possible target of modulatory events inducing protein 
phosphatases activation [22,24] and/or PKC inhibition. 
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